Top compounds associated with response to SLC29A4


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA apicidin CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.21 4e-05
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.43 4e-05
Download CSV